A comprehensive view of Pharmaxis Ltd.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Aptar Pharma acquires worldwide license for Orbital Dry Powder Inhaler from Pharmaxis for undisclosed amount; high payload Orbital technology delivers up to 400 mg of powders in divided doses without the need to reload
Published: August 10, 2022 by AptarGroup Inc.

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count